MedPath

Probiotic applications in obesity and related mood disorders

Phase 3
Conditions
Obesity with mood disorders.
Obesity due to excess calories
E66.0
Registration Number
IRCT20191127045525N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

?Willing to participate in the study
Age range of 18 to 50 years
Body Mass Index (BMI) =30 and waist circumference (WC) more than 85cm in women and 102 cm in men
Beck Depression Inventory (BDI) scores ranging between 17 to 40
Not taking probiotic supplements in the last 2 months and antibiotics in the last 3 months
Absence of chronic liver, kidney, cardiovascular, GI and infectious diseases as well as diabetes, and severe neurological and psychiatric disorders.
Not using anti-depressants
Not using antioxidants, omega-3 and magnesium supplements less than one month prior to study commencement
Not regular use of steroid and non-steroid anti-inflammatory drugs
No regular alcohol drinking or smoking, No opioid addiction
No history of heart attack, not being pregnant or intending pregnancy, not being in breastfeeding or menopausal states.

Exclusion Criteria

pregnancy, any significant change in diet or physical activity, starting new drugs or antibiotics, and not intending to continue study protocols.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Beck Depression Inventory (BDI) score. Timepoint: Before commencement and after 12 weeks of intervention. Method of measurement: Beck Depression Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath